794
Views
4
CrossRef citations to date
0
Altmetric
Articles

Acute and delayed cytopenias following CAR T-cell therapy: an investigation of risk factors and mechanisms

, , , , &
Pages 1849-1860 | Received 01 Oct 2021, Accepted 09 Mar 2022, Published online: 07 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mary McGann, Arash Velayati, Kiera Roubal, Katelynn Granger, James A. Davis, Kelly J. Gaffney, Erin Weeda & Hamza Hashmi. (2023) Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies. Leukemia & Lymphoma 64:9, pages 1592-1595.
Read now
Mark R. Dowling & Michael Dickinson. (2022) Post CAR-T cytopenia: poorly understood and clinically challenging. Leukemia & Lymphoma 63:8, pages 1774-1776.
Read now

Articles from other publishers (2)

Kathryn M. Cappell & James N. Kochenderfer. (2023) Long-term outcomes following CAR T cell therapy: what we know so far. Nature Reviews Clinical Oncology.
Crossref
Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Andrea Kuhnl, Nathalie Fegueux, Michael Daskalakis, Nicolaus Kröger, Peter Dreger, Caroline Besley, Urs Schanz, Adrian Bloor, Arnold Ganser, Edouard Forcade, Lucia López Corral, Jakob R Passweg, Urban Novak, Ivan Moiseev, Hélène Schoemans, Grzegorz W Basak, Christian Chabannon, Anna Sureda, Dina Averbuch, Bertram Glass, Rafael de la Camara & Zinaida Peric. (2023) Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party. Journal for ImmunoTherapy of Cancer 11:4, pages e006406.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.